Mitochondrial replacement therapy is an IVF-based reproductive technique designed to reduce the risk of a mother passing harmful mitochondrial DNA mutations to a child. It is not an anti-aging treatment. In the United States, FDA says human clinical research using MRT cannot legally proceed because Congress bars FDA from accepting applications for it 1.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What is mitochondrial replacement therapy?
Mitochondrial replacement therapy is a set of assisted-reproduction techniques designed to reduce the chance that a mother passes pathogenic mitochondrial DNA mutations to a child. The National Academies describes MRT as a reproductive option for women at risk of transmitting mitochondrial DNA disease, while noting major safety, ethical, and policy questions 2.
A plain-English definition
Mitochondria are tiny parts of cells that help make ATP, the cell’s usable energy, through oxidative phosphorylation. They also carry their own small set of DNA, called mitochondrial DNA or mtDNA, which is separate from nuclear DNA, or nDNA 2.
In MRT, doctors use in vitro fertilization, or IVF, to combine nuclear genetic material from the intended parents with donor mitochondria from an egg donor. This is why MRT is sometimes described as mitochondrial donation 2.
How mitochondrial DNA differs from nuclear DNA
Most human DNA is nuclear DNA. It sits in the nucleus and comes from both parents. Mitochondrial DNA is much smaller, sits inside mitochondria, and is passed from mother to child 1.
Some people have a mix of normal and mutated mtDNA, called heteroplasmy. If nearly all mtDNA copies are the same, that is called homoplasmy. The level and tissue pattern of mutated mtDNA can affect whether a person develops symptoms 2.
Why MRT is used for inherited mitochondrial DNA disease, not general longevity
MRT is aimed at inherited mitochondrial DNA disease, such as conditions that can include Leigh syndrome or MELAS when caused by mtDNA mutations. It is not designed to improve energy in adults, slow aging, or extend human lifespan 2.
This distinction matters in longevity research. Animal, cell, embryo, or biomarker findings can help scientists ask better questions, but they do not prove longer human life or clinical benefit in people.
Quick facts about mitochondrial replacement therapy
MRT is a reproductive medicine topic, not a telehealth medication topic. The most important facts are who it is for, what it can and cannot do, and why U.S. access is restricted.
| Question | Plain answer |
|---|---|
| What is MRT? | An IVF-based technique that transfers nuclear genetic material into an egg or zygote with donor mitochondria 2. |
| Who is it meant for? | Some women at risk of passing pathogenic mitochondrial DNA mutations to a child 2. |
| What does it not treat? | It does not treat general aging, low energy, common infertility, or mitochondrial disorders caused by nuclear DNA mutations. |
| What is the U.S. status? | FDA says human clinical research using MRT cannot legally proceed because Congress bars FDA from accepting applications 1. |
| Evidence level | Human use is tightly regulated and limited; much safety evidence comes from embryo, animal, cell, and early clinical experience, each with limits 2. |
How does mitochondrial replacement therapy work?
Mitochondrial donation uses IVF lab steps to move nuclear genetic material while trying to leave behind mutated maternal mtDNA. The main techniques are maternal spindle transfer, pronuclear transfer, and polar body transfer 2.
Maternal spindle transfer
Maternal spindle transfer, or MST, happens before fertilization. The spindle containing the mother’s chromosomes is removed from her oocyte, placed into a donor oocyte that has had its own spindle removed, and then fertilized through IVF 2.
Animal evidence helped develop this approach. In a 2009 rhesus macaque study, researchers reported healthy offspring after spindle transfer, but animal births do not prove the same long-term safety in humans 6.
Pronuclear transfer
Pronuclear transfer, or PNT, happens after fertilization but before the maternal and paternal pronuclei fuse. The pronuclei from the intended parents’ zygote are moved into a donor zygote whose pronuclei have been removed 2.
Human embryo research has studied PNT, including how much mutated mtDNA may carry over and whether embryos develop normally in the lab. These embryo studies are important, but they are not the same as proof of long-term health in children 7.
Polar body transfer
Polar body transfer, or PBT, uses small cells produced during egg development that contain chromosomes but little cytoplasm. It is less established than MST and PNT, and much of the evidence remains preclinical 2.
Why IVF is part of the process
MRT requires IVF because the egg, sperm, embryo, and donor mitochondria must be handled in a specialized embryology lab. It is not a medication, supplement, injection, or at-home treatment 2.
Who might consider mitochondrial replacement therapy?
MRT may be considered only in a narrow reproductive setting: a woman has a known pathogenic mtDNA mutation and wants to reduce the risk of passing it to a child. This decision belongs with reproductive endocrinology, genetics, and mitochondrial disease specialists 2.
Mothers with pathogenic mitochondrial DNA mutations
Because mtDNA is inherited through the maternal line, MRT is relevant when the egg carries a harmful mtDNA mutation. The goal is to lower the child’s exposure to that maternal mtDNA mutation by using donor mitochondria 1.
Why MRT does not apply to nuclear DNA mitochondrial disorders
Many mitochondrial disorders come from variants in nuclear DNA, not mtDNA. MRT does not replace nuclear DNA, so it cannot remove a nuclear DNA variant that affects mitochondrial function 2.
How genetic counseling fits into decision-making
Genetic counseling helps families understand inheritance, testing, alternatives, and uncertainty. It also helps clarify whether a condition is linked to mtDNA, nuclear DNA, or another cause 2.
Why is mitochondrial replacement therapy restricted in the United States?
FDA says clinical research using MRT in humans cannot legally proceed in the United States. Since December 2015, Congress has included provisions in federal appropriations laws that prohibit FDA from accepting applications for this type of clinical research 1.
FDA’s role in regulating MRT
FDA states that clinical use of MRT falls within its regulatory authority because MRT introduces donor mitochondria into reproductive cells intended for transfer into a human recipient. FDA also notes that the technique introduces genetic modification and raises safety concerns 1.
The congressional restriction on accepting clinical research applications
The U.S. restriction is not simply a clinic policy. FDA says Congress has barred the agency from accepting applications for clinical research using MRT, which means human clinical research cannot legally proceed in the United States under the current advisory 1.
Why germline genetic change raises legal and ethical concerns
MRT can affect the germline, meaning the mitochondrial DNA pattern may be passed to future generations. The National Academies report highlights ethical and social questions about future children, donor involvement, informed consent, and public oversight 2.
What are the possible benefits and risks of MRT?
MRT’s possible benefit is specific: lowering the chance of maternal transmission of serious mtDNA disease. The risks include mtDNA carryover, embryo development concerns, unknown long-term outcomes, and ethical questions 2.
Potential benefit: reducing maternal transmission of mitochondrial DNA disease
For some families, MRT could provide a reproductive path when a mother has a high risk of passing mtDNA disease. The National Academies describes this as the central potential use of MRT, while emphasizing that rare, severe mitochondrial diseases are hard to study 2.
Safety concerns: carryover of mutated mtDNA and embryo development
A key safety concern is carryover: a small amount of maternal mtDNA may move with the nuclear material. Cell and embryo research has raised concern that carried-over mtDNA could expand in some settings, which may reduce the intended effect 8.
Embryo development is another concern because MRT changes the egg or zygote at a very early stage. Human embryo studies can show lab development patterns, but they cannot prove lifelong safety 7.
Ethical concerns: donor mitochondria, future generations, and consent
MRT involves donor mitochondria, intended parents’ nuclear DNA, and a future child who cannot consent. The National Academies report and regulatory reviews discuss consent, identity, follow-up, fairness, and effects on future generations 2.
Evidence limits: what human, animal, and cell research can and cannot show
Human clinical evidence for mitochondrial disorders is difficult because these diseases are rare, varied, and often affect many organs. A 2020 review noted that mitochondrial disease trials face major challenges from small sample sizes, heterogeneity, and limited validated outcomes 9.
Animal evidence can show whether offspring are born and followed in controlled settings. Cell and embryo evidence can show development and mtDNA behavior in the lab. None of these evidence types proves that MRT extends human lifespan or works as a general longevity therapy.
Which countries allow mitochondrial replacement therapy?
MRT access varies by country and can change. The United Kingdom created a regulated, case-by-case pathway, while the United States blocks human clinical research under FDA’s current advisory 1, 3.
United Kingdom: regulated, case-by-case use
In the United Kingdom, the Human Fertilisation and Embryology Authority, or HFEA, regulates mitochondrial donation. HFEA describes mitochondrial donation treatment as tightly controlled and available only in specific circumstances through licensed centers 3.
United States: human clinical research cannot legally proceed under FDA’s current advisory
In the United States, FDA says it cannot accept applications for clinical research using MRT because of congressional restrictions. FDA also says it maintains authority to investigate and take enforcement action if it becomes aware of noncompliance 1.
Why readers should verify current rules with official regulators before acting
Rules can change, and cross-border fertility care has medical, legal, and ethical risks. Before making decisions, families should check official regulator websites and speak with a reproductive endocrinologist, genetic counselor, and mitochondrial disease specialist.
Is mitochondrial replacement therapy the same as mitochondrial transplantation or mitochondrial support?
MRT is not the same as autologous mitochondrial transplant, supplements, exercise, or general mitochondrial support. MRT is a reproductive IVF procedure; the others are different medical or wellness concepts.
MRT versus autologous mitochondrial transplant
Autologous mitochondrial transplant usually means using a person’s own mitochondria in another tissue context. For example, a registered clinical study has evaluated autologous mitochondrial transplant for cerebral ischemia, which is different from reproductive MRT 10.
MRT versus supplements, diet, and exercise
Diet, exercise, sleep, and cardiometabolic care can support general health, and exercise can improve mitochondrial function markers in human studies. But these are not substitutes for MRT, genetic counseling, or care for suspected mitochondrial disease 11.
At Chia, we cover mitochondrial and longevity topics as education. Some Chia-offered longevity treatments, such as NAD+, glutathione, and sermorelin, are available only after a licensed-provider evaluation when clinically appropriate. Compounded medications are not FDA-approved, eligibility is not guaranteed, and these products are not substitutes for MRT or care for mitochondrial disease.
Why mitochondrial biomarkers are not proof of longer human lifespan
A biomarker is a measurement, not a patient-centered outcome. Better mitochondrial markers in a study do not automatically mean fewer symptoms, fewer inherited disorders, or longer human life.
Does Chia offer mitochondrial replacement therapy?
Chia does not offer MRT, IVF, embryo procedures, fertility procedures, genetic testing for embryo selection, or reproductive surgery. MRT is not available as a telehealth prescription medication.
Chia does not offer MRT or fertility procedures
We are a licensed telehealth clinic for specific compounded medications and longevity protocols listed in our public catalog. MRT is outside that scope because it requires specialized fertility care, an embryology lab, and regulator-approved reproductive medicine pathways.
How Chia covers mitochondrial and longevity topics as education
We write about mitochondrial science because many patients ask about energy, aging, and longevity. We separate reproductive MRT from general mitochondrial support so readers do not confuse a restricted IVF technique with wellness care.
When to seek a reproductive endocrinologist, genetic counselor, or mitochondrial disease specialist
If you have a known mtDNA mutation, a child with suspected mitochondrial disease, or a family history of severe neurologic, muscle, heart, or metabolic symptoms, a specialist evaluation is the right next step. A genetic counselor can help explain inheritance and testing options.
What can people do to support mitochondrial health safely?
Mitochondrial health is best supported through the basics that also support metabolic health: regular movement, enough sleep, blood pressure control, glucose control, and not smoking. These steps do not replace care for inherited mitochondrial disease.
Food patterns that support general metabolic health
Food patterns rich in minimally processed plants, adequate protein, healthy fats, and fiber support general cardiometabolic health. For people with confirmed mitochondrial disease, nutrition plans should be individualized by clinicians familiar with the disorder 9.
Exercise, sleep, and cardiometabolic risk factors
Human exercise studies show that aerobic and resistance training can change mitochondrial function markers in muscle, but those findings are not the same as treating inherited mtDNA disease or extending lifespan 11.
When symptoms need medical evaluation rather than wellness advice
Seek medical care for unexplained severe fatigue, exercise intolerance, seizures, developmental delay, vision or hearing loss, muscle weakness, heart rhythm problems, or repeated metabolic crises. These symptoms need clinical evaluation, not a wellness plan.
FDA says human clinical research using MRT cannot legally proceed in the United States because Congress bars FDA from accepting applications for that research. FDA also says MRT introduces donor mitochondria into reproductive cells and raises safety concerns.
Some people use that phrase, but it can be misleading. Most DNA would come from the intended parents’ nuclear DNA. The donor contributes mitochondria and mitochondrial DNA, which is a much smaller genetic contribution.
MRT is not a cure for a person who already has mitochondrial disease. It is a reproductive technique designed to reduce the chance that a mother passes certain mitochondrial DNA mutations to a future child.
MRT has been discussed in fertility settings, but its main regulated purpose is reducing transmission of pathogenic mitochondrial DNA mutations. It should not be viewed as a routine infertility treatment.
No food can repair inherited mitochondrial DNA mutations. A healthy food pattern can support general metabolic health, but suspected mitochondrial disease needs medical and genetic evaluation.
No. MRT is an IVF-based reproductive procedure that requires a fertility clinic, embryology lab, specialist care, and legal oversight. Chia does not offer MRT or fertility procedures.
No. MRT is intended to reduce maternal transmission of pathogenic mitochondrial DNA mutations. It is not an anti-aging, longevity, energy, or wellness treatment.
Start with a reproductive endocrinologist and a genetic counselor. If mitochondrial disease is suspected or confirmed, a mitochondrial disease specialist can help interpret testing and care options.
References
- 1.U.S. Food and Drug Administration. Advisory on Legal Restrictions on the Use of Mitochondrial Replacement Techniques to Introduce Donor Mitochondria into Reproductive Cells Intended for Transfer into a Human Recipient. FDA, 2024.
- 2.National Academies of Sciences, Engineering, and Medicine. Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations. National Academies Press, 2016.
- 3.Human Fertilisation and Embryology Authority. Mitochondrial donation treatment. HFEA, 2024.
- 4.Adashi EY, Cohen IG. Mitochondrial Replacement Therapy: The IOM Report and Its Aftermath. JAMA, 2016.
- 5.Ishii T, Hibino Y. Mitochondrial manipulation in fertility clinics: regulation and responsibility. Reproductive BioMedicine Online, 2018.
- 6.Tachibana M, Sparman M, Sritanaudomchai H, et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature, 2009.
- 7.Hyslop LA, Blakeley P, Craven L, et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. Nature, 2016.
- 8.Kang E, Wu J, Gutierrez NM, et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature, 2016.
- 9.Martínez-Reyes I, Chandel NS. Clinical trials in mitochondrial disorders, an update. Molecular Genetics and Metabolism, 2020.
- 10.ClinicalTrials.gov. Autologous Mitochondrial Transplant for Cerebral Ischemia. National Library of Medicine, 2024.
- 11.Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster BH. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. Journals of Gerontology Series A, 2006.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
